Skip to search formSkip to main contentSkip to account menu

MedImmune, Inc.

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A Double-masked, Placebo-controlled Study with Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adult Subjects with Neuromyelitis Optica Spectrum Disorders–Top line efficacy…
Objective: To evaluate the safety and efficacy on relapse prevention, of inebilizumab, an anti-CD19, B-cell depleting monoclonal… 
2016
2016
High affinity recognition of a selected amino acid epitope within a protein by CB [ 8 ] complexation ∗ ∗
Supramolecular interactions between the host cucurbit[8]uril (CB[8]) and amino acids have been widely interrogated, but… 
2009
2009
Non-Safety Voluntary Recall of H1N1 Nasal Spray Vaccine
Bakersfield - MedImmune, a manufacturer of H1N1 Nasal Spray, has issued a non-safety voluntary recall of 1/5 of its H1N1 Nasal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)